Active	Status	Sponsor type	Region	Phase	Filter
1 Active 2 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Böhner, Alexander
DUPINUM, NCT04600362: Study of Dupilumab to Demonstrate Efficacy in Subjects With Nummular Eczema	Recruiting	2	70	Europe	Experimental: Dupilumab 300 MG/2 ML Subcutaneous Solution [DUPIXENT]	Technical University of Munich, University Hospital Munich	Nummular Eczema	01/26	01/27